ArticleScience advances2020

In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair.

Bong-Woo Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.